by the FDA The previous FDA-approved maximum dose of semaglutide for weight loss was 2.4 mg weekly by injection (Wegovy) Rushing your dose increase can backfire
Direct answer: Yes, routine labs help monitor safety and effectiveness
Before its availability, patients who could benefit from GLP-1 receptor agonists were limited to injectable formats, which posed adherence challenges for some individuals
Customer Service Comment : We emailed Brello with a basic question
It is safer to use one vial at a time and reconstitute new vials at your preferred concentration rather than trying to mix concentrations mid-treatment
Patients with a BMI between 27 and 30 may qualify for this treatment if they also have a weight-related health concern, such as type 2 diabetes, high blood pressure, sleep apnea, or high cholesterol